News
Search Results
Child Being Investigated for Hepatitis
PIERRE, S.D. The South Dakota Department of Health (DOH) is investigating a child with hepatitis of unknown origin. The child resides in Brown County and is under 10 years of age.
SD-DOH Announces Available Grants for 2022 Mosquito Control Programs
The South Dakota Department of Health (SD-DOH) today announced that cities, counties, and tribes can apply, or reapply, to obtain state grant funding to help control mosquito populations and prevent the spread of West Nile virus (WNV).
DOH Completes Statewide Distribution of One Million Free COVID-19 Test Kits
The South Dakota Department of Health (SD-DOH) announced today it has completed its statewide distribution of one million Flowflex® COVID-19 at-home antigen tests.
DOH Statewide Distribution of Free COVID-19 Tests Continues
The South Dakota Department of Health (SD-DOH) continued its operations to distribute one million Flowflex® COVID-19 Antigen home tests to sites across the state.
Department of Health Begins Statewide Distribution of One Million Free COVID-19 Tests
Today, the South Dakota Department of Health (SD-DOH) began operations to promptly and efficiently distribute one million Flowflex® COVID-19 antigen home tests to sites across the state.
Department of Health Makes an Additional One Million Free COVID-19 Tests Available to State Resident
Today, the South Dakota Department of Health (DOH) announced it has procured one million Flowflex® COVID-19 Antigen home tests.
CDC Expands Booster Shot Eligibility and Strengthens Recommendations for 12-17 Year Olds
Today, CDC is endorsing the Advisory Committee on Immunization Practices’ (ACIP) recommendation to expand eligibility of booster doses to those 12 to 15 years old. CDC now recommends that adolescents age 12 to 17 years old should receive a booster shot 5 months after their initial Pfizer-BioNTech vaccination series.
CDC Recommends Pfizer Booster at 5 Months, Additional Primary Dose for Certain Immunocompromised Children
CDC is updating our recommendation for when many people can receive a booster shot, shortening the interval from 6 months to 5 months for people who received the Pfizer-BioNTech COVID-19 Vaccine.
Coronavirus (COVID-19) Update: FDA Authorizes First Oral Antiviral for Treatment of COVID-19
Given what we currently know about COVID-19 and the Omicron variant, CDC is shortening the recommended time for isolation for the public.
Coronavirus (COVID-19) Update: FDA Authorizes Additional Oral Antiviral for Treatment of COVID-19 in Certain Adults
The FDA issued an emergency use authorization for Merck’s molnupiravir for the treatment of mild-to-moderate COVID-19 in certain adults.